• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Genzyme `s Biologic Fabrazyme (Agalsidase Beta) Receives Suppl Approvals in US

    FDA

    Appeals court revives litigation centered on Sanofi`s Fabrazyme

    FIERCE PHARMA

    Genzyme`s Biologic Fabrazyme (agalsidase beta) Receives Approval in the U.S.

    FDA

    Astellas Announces Positive Safety Data from FORTIS Study of AT845

    PRNEWSWIRE

    Sangamo Updates Prelim Phase 1/2 Data Showing Tolerability & Sustained Activity

    BUSINESSWIRE

    Chiesi’s flagship Fabry drug heads for FDA verdict in early 2021

    PHARMAPHORUM

    Will sky-high drug prices spur the US to use an obscure power over patents?

    BIO PAHRAMDIVE

    Genzyme`s Fabrazyme (Agalsidase Beta) Receives Supplemental Approval in US

    FDA

    Protalix, Chiesi fire up accelerated approval pitch for Fabry disease treatment

    ENDPTS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.